Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 26.68 CNY -1% Market Closed
Market Cap: 39.6B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

25.9
Current
28.1
Median
23.2
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
25.9
=
Enterprise Value
42.3B CNY
/
EBIT
1.6B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
23.4
2-Years Forward
EV/EBIT
20
3-Years Forward
EV/EBIT
17

See Also

Discover More